AQPs are also targets for many diseases, such as pyelonephritis and IgA nephropathy, in which abnormal levels of AQP2 can be detected in the urine, suggesting that AQP2 may be a therapeutic target for this disease [24,25]. Here, AQP2 is linked to IgA glomerulonephritis.